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ABSTRACT 
Background: Acute ST-segment–elevation myocardial infarction (STEMI) is a disease of high 
mortality and morbidity, and primary percutaneous coronary intervention (PPCI) is the 
preferred therapy for patient in golden period or with hemodynamic instability.1,2 Currently the 
world has been declared under COVID-19 (coronavirus disease 2019) pandemic by the World 
Health Organization (WHO).3 Signs and symptoms of COVID-19 patients can mimic acute 
decompensated heart failure, or induce acute cardiovascular problem.3 Screening is key, but 
there are conditions where physicians might miss positive COVID-19 cases, especially in 
critical cardiovascular emergency. 
Case Illustration: A 60-year old male came to emergency room with breathlessness and chest 
pain 8 hours prior. He was diagnosed as acute inferior STEMI with acute lung edema and 
cardiogenic shock (KILLIP IV, acute heart failure wet and cold). COVID-19 screening was 
negative. Patient underwent PPCI, found to have total occlusion of right coronary artery (RCA) 
with thrombus and tight stenosis in left coronary artery (LAD). Successful PPCI to RCA was 
performed with TIMI 3 flow result, and hemodynamic improved. Ten hours after PPCI, 
hemodynamic deteriorated and peripheral oxygen saturation dropped. Patient was intubated and 
put on ventilator. Repeated chest X-Ray and thoracic CT showed lung condition has abruptly 
worsened  – with ground glass opacity (GGO) found. His condition worsened quickly, and 
family agreed to a do not resuscitate (DNR) consent. 
Conclusion: Acute cardiovascular condition in COVID-19 Pandemics represent big 
challenges, especially in early diagnostic and cardiovascular intervention decision. We were 
presenting a case where signs and symptoms of COVID-19 might appear later. Therefore, in 
this pandemic era every emergency cardiovascular intervention with signs of respiratory 
problem should be performed as if patient was a positive COVID-19 case. 
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INTRODUCTION 
 Acute ST segment elevation myocardial infarction (STEMI) is a disease of high 
mortality and morbidity, and when the onset is less than 12 hours, primary percutaneous 
coronary intervention (PPCI) is the preferred therapy.1,2 Regardless of the time from symptoms 
onset, the presence of ongoing ischemic symptoms, life threatening arrhythmias, and 
haemodynamic instability is an indication for a PPCI strategy.1  
 On 30thJanuary 2020, WHO declared the outbreak of severe acute respiratory syndrome 
coronavirus 2 (SARS-CoV-2) a pandemic.3 Multiple reports showed that signs and symptoms 
of COVID-19 (the official disease name of SARS-COV-2 virus infection) patients can mimic 
acute heart problem such as acute decompensated heart failure, or induce acute cardiovascular 
problem.3 
 PPCI decision is dilemmatic in COVID-19 era, and if decided to be performed has to 
be made after a proper screening. In a suspected COVID-19 patient, thrombolytics should be 
preferred over PPCI, if possible. But in STEMI cases with hemodynamic instability or life 
threatening condition, the decision could mean life or death for the patient. In this situation, 
decision to perform emergency cardiovascular intervention will be challenged to the limit.4,5 
 
CASE ILLUSTRATION 
 A 60-year old male patient came to our emergency unit with breathlessness and severe 
chest pain which started 8 hours before hospital admission. His heart rate was 55 bpm , blood 
pressure 100/60 mmHg, with 88%-92% peripheral O2 saturation. Rales were found in  in two – 
third of basal bilateral area of the lung. ECG showed sinus rhythm 55 bpm with elevated ST 
segment in infero-posterior leads. He was diagnosed as acute infero-posterior STEMI with 
acute lung edema and cardiogenic shock (KILLIP IV, acute heart failure wet and cold). Patient 
denied any history of fever, cough, or flu-like symptoms beforehand and contacts with known 
suspected or confirmed COVID-19 patients. Thoracic X-ray showed pulmonary vascular 
redistribution typical of lung edema without typical bilateral infiltrates.  On
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Figure1. ECG showed first degree AV block with ST elevation in inferior and posterior leads 
(and reciprocal in anterior leads). 
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 Figure2. Thoracal X-Ray on admission shows pulmonary vascular redistribution typical of 
lung edema, but no typical peripheral bilateral consolidation. 
 
PPCI was performed, and coronary angiography showed triple vessel disease with total 
occlusion in Right Coronary Artery (RCA) and 90% stenosis of  Left Anterior Descending 
(LAD) artery. One Drug Eluting Stent (DES) was successfully inserted in RCA with TIMI 3 
flow result. Hemodynamic improved after the procedure, and patient moved to intensive care 
unit.  O
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 Figure 3. Culprit lesion in Right Coronary Artery (RCA). One Drug Eluting Stent (DES) was 
successfully deployed with final TIMI 3 flow result. 
 
Ten hours after PPCI, patient condition deteriorated. Blood pressure down to 86/68 
mmHg, heart rate increased to 110 bpm, and peripheral Oxygen saturation down to 85%. Blood 
gas analysis showed severe respiratoric and metabolic acidosis. Patient were intubated. 
Repeated chest X-Ray showed diffuse infiltrate in both sides of the lung. Thorax CT Scan was 
performed, and typical ground glass opacity signs (GGO) were observed. Repeated diff count 
showed a low lymphocyte count of 3%. Patient was assessed as a probable COVID-19 because 
of the typical chest X-Ray and CT Finding. 
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 Figure 4. Repeated chest X-Ray showed diffuse infiltrate and peripheral consolidation in both 
sides of the lung.  
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Figure5. Typical ground glass opacity (GGO) signs were observed in Thoracic CT 
examination. 
 
After 6 hours treated in ICU, having triple inotropic agents and mechanical ventilation 
supports, hemodynamic did not improved. Thorough explanation of the diagnosis and prognosis 
was delivered to the family, and they signed a consent for a do-not-resuscitate protocol. Patient 
did not survive. 
 
DISCUSSION 
 In patients with clinical suspicion of myocardial infarction with ST segment elevation, 
reperfusion therapy needs to be initiated as soon as possible. PPCI is the preferred strategy if 
the onset <12 hours or if hemodynamic condition unstable. Primary PCI is superior to 
fibrinolysis in reducing mortality, reinfarction, or stroke.1 However, in COVID-19 pandemics 
era, major cardiovascular society has modified their guidelines – SCAI (Society for 
Cardiovascular Angiography & Interventions, U.S.A) and IHA (Indonesian Heart Association, 
Indonesia) has issued a modified algorithm which prefer fibrinolytic therapy over PPCI in 
patients with STEMI and COVID-19 suspect.4,5,6 
 Our hospital adopted these, especially IHA’s modified STEMI guidelines where all 
STEMI patients will be screened for possibility of infection. Negative patients should be treated 
according to standard STEMI guidelines. In patients under investigation or confirmed COVID-
19 case, patients will be classified by the severity of pneumonia manifestation and 
hemodynamic condition. If the patient is in mild-moderate pneumonia and hemodynamically 
stable, fibrinolytic therapy is indicated over PCI. In hemodynamically unstable condition, 
patient will have PPCI in isolated catheterization laboratory, if the benefit overcome the risk.5,6 
The problem with clinical criteria for COVID-19 in acute cardiovascular condition is 
that the signs and symptoms can be difficult to differentiate, or even overlapping. Before 
COVID-19 era, STEMI cases with respiratory problem, will be treated as STEMI with 
complication. In our patient, even when the lab and chest x-ray was not indicating COVID-19, 
and there was a better explanation for the condition than COVID-19, signs and symptoms of 
severe pneumonia with typical COVID-19 appearance showed later. Swab test was failed to be 
performed on this patient, as the test kit for COVID-19 was heavily undersupplied at the time, 
in-house laboratory not trained yet, and a very long que in official government lab. Diagnosis 
of COVID-19 suspect was made from CT-Scan and lab result. The positive and negative 
predictive value of chest CT for COVID-19 are estimated at 92% and 42%, respectively, 
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moreover when the findings is a peripheral distribution of GGO, a distinctive COVID-19 
marker. It is justified to say that thorax CT finding may not suitable as screening test for 
diagnosing COVID-19, but when the signs appear, is most likely confirmed to be one.7 Under 
WHO guideline, our patient is considered a suspected case as CT findings is sufficient to be 
evidence of COVID-19 infection case, whereas to be confirmed patients need to undergo RT-
PCR confirmation testing. All suspected case without testing or the result is inconclusive are 
considered to be a probable case, much as like our patient was.8 
Worsening of the respiratory system, leading to acute respiratory distress syndrome 
(ARDS) and shock leads physicians to a high suspicion of SARS-CoV-2 Infection in this 
pandemic era. Although highly probable, the exact cause of ARDS development cannot be 
pinpointed because RT-PCR was not available at that time. Reperfusion injury is one of the 
possibility of causing ARDS and rapid deterioration, causing the same cytokine storm just as 
in severe case of COVID-19. However, ARDS after PPCI is not a common case, at least not 
before COVID-19 Pandemics. And the prevalence of ARDS that caused by reperfusion injury 
is unknown.9,10 
Cardiopulmonary resuscitation (CPR) in COVID-19 patient is also dilemmatic. When 
the prognosis is poor with heavy underlying condition, IHA has issued a modified version of 
their CPR criteria and algorithm. Whenever the patient has a poor prognosis and the risk of 
exposure to healthcare worker is high, it is possible to not perform CPR. A careful explanation 
and consent to the family has to be made prior to the decision.11 
 
CONCLUSION 
 Acute cardiovascular condition in COVID-19 pandemics represent big challenges, 
especially in STEMI patients with unstable hemodynamic and respiratory problem. We were 
presenting a case where signs and symptoms of COVID-19 might appear later. Therefore every 
emergency cardiovascular intervention, especially the one with any signs of respiratory 
problem must be performed as if patient was a positive COVID-19 case. Many cardiac societies 
around the world  have issued their modified algorithm about treatment of acute cardiovascular 
condition in COVID-19 era and should be adopted.  
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